| 摘要: |
| 乳腺癌的靶向治疗研究已经成为乳腺癌治疗领域研究的热点, 是继手术、放疗和化疗三大传统模式之后一种全新的生物治疗模式。分子靶向治疗是指针对乳腺癌发生、发展有关的信号通路及其癌基因相关表达产物进行治疗。本文分别对以HER-2、VEGF、EGFR为靶点及多靶点等4个研究领域的靶向治疗最新进展进行综述。 |
| 关键词: 乳腺癌 靶向治疗 进展 |
| DOI：10.11724/jdmu.2013.05.22 |
| 分类号: |
| 基金项目: |
|
| Advances in targeted therapy of breast cancer |
|
SU Hui， GAO Ya-jie，ZHANG Chun-xia
|
|
Department of Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
|
| Abstract: |
| Currently targeted therapy of breast cancer has become the hot research field and a kind of brand-new biological treatment mode after three traditional pattern of the surgery, radiotherapy and chemotherapy for breast cancer. Molecular targeted therapy is aimed at the occurrence and development of cancer-related signaling pathways and gene expression products. Four research fields on targeted therapy of breast cancer were reviewed in this paper with HER-2,VEGF,EGFR and multiple targets therapy. |
| Key words: breast cancer targeted therapy progress |
